Ultra-small particles loaded with medicine - and aimed with the precision of a rifle - are offering a promising new way to strike at cancer, according to researchers working at MIT and Brigham and Women’s Hospital.
In a paper to appear the week of April 10 in the online edition of the Proceedings of the National Academy of Sciences, the team reports a way to custom design nanoparticles so they home in on dangerous cancer cells, then enter the cells to deliver lethal doses of chemotherapy. Normal, healthy cells remain unscathed.
The team conducted experiments first on cells growing in laboratory dishes, and then on mice bearing human prostate tumors. The tumors shrank dramatically, and all of the treated mice survived the study; the untreated control animals did not.
"A single injection of our nanoparticles completely eradicated the tumors in five of the seven treated animals, and the remaining animals also had significant tumor reduction, compared to the controls," said Dr. Omid C. Farokhzad, an assistant professor at Brigham and Women’s Hospital and Harvard Medical School.
Farokhzad and MIT Institute Professor Robert Langer led the team of eight researchers. (Farokhzad was formerly a research fellow in Langer’s lab.)
The scientists said that further testing is needed. Although all the parts and pieces of their new system are known to be safe, the system itself must yet be proven safe and effective in humans. This means thorough testing must be done in larger animals, and eventually in humans.
"We’re most interested in developing a system that ends up in the clinic helping patients," Farokhzad said. To make that happen, he added, "we brought in cancer specialists and urologists to collaborate with us."
Further, he said, from an engineering perspective "we wanted to develop a broadly applicable system, one that other investigators can alter for their own purposes."
For example, Langer said, researchers "can put different things inside, or other things on the outside, of the nanoparticles. In fact, this technology could be applied to almost any disease" by re-engineering the nanoparticles’ properties. The nanoparticles work like a bus that can safely carry different passengers to different destinations.
In the study, Farokhzad, Langer and colleagues tailor-made tiny sponge-like nanoparticles laced with the drug docetaxel. The particles are specifically designed to dissolve in a cell’s internal fluids, releasing the anti-cancer drug either rapidly or slowly, depending on what is needed. These nanoparticles were purposely made from materials that are familiar and approved for medical applications by the U.S. Food and Drug Administration. Thus all of the ingredients are known to be safe.
Also, to make sure only the correct cells are hit, the nanoparticles are "decorated" on the outside with targeting molecules called aptamers, tiny chunks of genetic material. Like homing devices, the aptamers specifically recognize the surface molecules on cancer cells, while avoiding normal cells. In other words, the bus is driven to the correct depot.
In addition, the nanoparticles also display polyethylene glycol molecules, which keep them from being rapidly destroyed by macrophages, cells that guard against foreign substances entering the body.
The team chose nanoparticles as drug-delivery vehicles because they are so small that living cells readily swallow them when they arrive at the cell’s surface. Langer said that particles larger than 200 nanometers are less likely to get through a cell’s membrane. A nanometer is one-billionth of a meter.
The Farokhzad-Langer team created particles that are about 150 nanometers in size: a thousand sitting side by side might equal the width of a human hair.
Elizabeth Thomson | EurekAlert!
Don't Give the Slightest Chance to Toxic Elements in Medicinal Products
23.03.2018 | Physikalisch-Technische Bundesanstalt (PTB)
North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich
Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.
The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
23.03.2018 | Event News
19.03.2018 | Event News
16.03.2018 | Event News
23.03.2018 | Materials Sciences
23.03.2018 | Agricultural and Forestry Science
23.03.2018 | Physics and Astronomy